Is C4 Therapeutics, Inc. (CCCC) a Buy, Sell, or Hold?
NASDAQ : CCCC
C4 Therapeutics, Inc.
$3.8 USD
-$0.01 (-0.26%)
- Volume
- 4.01M
- Average Volume
- 3.12M
- Market Capitalization
- $314.74M
- P/E Ratio
- -3.19
- Dividend Yield
- 0.00%
- Price Target
- $7.00
- Year High
- $5.17
- Year Low
- $1.69
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.00
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
36
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
14
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$122.47K
CCCC Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CCCC Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| REYNO LEONARD | officer: Chief Medical Officer | 2026-07-10 | M-Exempt | 0 | 2026-07-13 |
| REYNO LEONARD | officer: Chief Medical Officer | 2026-07-10 | F-InKind | 4.06 | 2026-07-13 |
| Anderson Kenneth Carl | director | 2026-07-01 | A-Award | 4.34 | 2026-07-02 |
| GROGAN DONNA ROY | director | 2026-07-01 | A-Award | 4.34 | 2026-07-02 |
| Hughes Owen | director | 2026-06-24 | A-Award | 4.25 | 2026-06-26 |
| Hoerter Steven L. | director | 2026-06-24 | A-Award | 4.25 | 2026-06-26 |
| Koppikar Utpal | director | 2026-06-24 | A-Award | 4.25 | 2026-06-26 |
| Anderson Kenneth Carl | director | 2026-06-24 | A-Award | 4.25 | 2026-06-26 |
| Cooper Ronald Harold Wilfred | director | 2026-06-24 | A-Award | 4.25 | 2026-06-26 |
| Bessen Laura | director | 2026-06-24 | A-Award | 4.25 | 2026-06-26 |
| Fawell Stephen | director | 2026-06-24 | A-Award | 4.25 | 2026-06-26 |
| GROGAN DONNA ROY | director | 2026-06-24 | A-Award | 4.25 | 2026-06-26 |
| Anderson Kenneth Carl | director | 2026-06-01 | M-Exempt | 2.11 | 2026-06-04 |
| Anderson Kenneth Carl | director | 2026-06-01 | M-Exempt | 2.11 | 2026-06-04 |
| Anderson Kenneth Carl | director | 2026-04-01 | A-Award | 2.7 | 2026-04-03 |
| GROGAN DONNA ROY | director | 2026-04-01 | A-Award | 2.7 | 2026-04-03 |
| Boyle Scott N | officer: Chief Business Officer | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Boyle Scott N | officer: Chief Business Officer | 2026-02-13 | A-Award | 0 | 2026-02-18 |
| Boyle Scott N | officer: Chief Business Officer | 2026-02-13 | F-InKind | 1.89 | 2026-02-18 |
| Boyle Scott N | officer: Chief Business Officer | 2026-02-14 | M-Exempt | 0 | 2026-02-18 |
| Boyle Scott N | officer: Chief Business Officer | 2026-02-14 | F-InKind | 1.89 | 2026-02-18 |
| Mahaney Paige | officer: Chief Scientific Officer | 2026-02-13 | A-Award | 0 | 2026-02-18 |
| Mahaney Paige | officer: Chief Scientific Officer | 2026-02-14 | M-Exempt | 0 | 2026-02-18 |
| Mahaney Paige | officer: Chief Scientific Officer | 2026-02-14 | F-InKind | 1.89 | 2026-02-18 |
| Schick Kelly | officer: Chief People Officer | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Schick Kelly | officer: Chief People Officer | 2026-02-13 | A-Award | 0 | 2026-02-18 |
| Schick Kelly | officer: Chief People Officer | 2026-02-13 | F-InKind | 1.89 | 2026-02-18 |
| Schick Kelly | officer: Chief People Officer | 2026-02-14 | M-Exempt | 0 | 2026-02-18 |
| Schick Kelly | officer: Chief People Officer | 2026-02-14 | F-InKind | 1.89 | 2026-02-18 |
| Hirsch Andrew | director, officer: President & CEO | 2026-02-13 | A-Award | 0 | 2026-02-18 |
| Hirsch Andrew | director, officer: President & CEO | 2026-02-14 | M-Exempt | 0 | 2026-02-18 |
| Hirsch Andrew | director, officer: President & CEO | 2026-02-14 | F-InKind | 1.89 | 2026-02-18 |
| Hirsch Andrew | director, officer: President & CEO | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Hirsch Andrew | director, officer: President & CEO | 2026-02-15 | F-InKind | 1.89 | 2026-02-18 |
| REYNO LEONARD | officer: Chief Medical Officer | 2026-02-14 | M-Exempt | 0 | 2026-02-18 |
| REYNO LEONARD | officer: Chief Medical Officer | 2026-02-13 | A-Award | 0 | 2026-02-18 |
| REYNO LEONARD | officer: Chief Medical Officer | 2026-02-14 | F-InKind | 1.89 | 2026-02-18 |
| Adams Kendra | officer: Chief Financial Officer | 2026-02-13 | M-Exempt | 0 | 2026-02-18 |
| Adams Kendra | officer: Chief Financial Officer | 2026-02-13 | A-Award | 0 | 2026-02-18 |
| Adams Kendra | officer: Chief Financial Officer | 2026-02-13 | F-InKind | 1.89 | 2026-02-18 |
| Adams Kendra | officer: Chief Financial Officer | 2026-02-14 | M-Exempt | 0 | 2026-02-18 |
| Adams Kendra | officer: Chief Financial Officer | 2026-02-14 | F-InKind | 1.89 | 2026-02-18 |
| Mossler Mark | officer: Chief Accounting Officer | 2026-02-13 | A-Award | 0 | 2026-02-18 |
| Mossler Mark | officer: Chief Accounting Officer | 2026-02-14 | M-Exempt | 0 | 2026-02-18 |
| Mossler Mark | officer: Chief Accounting Officer | 2026-02-14 | F-InKind | 1.89 | 2026-02-18 |
| REYNO LEONARD | officer: Chief Medical Officer | 2026-01-16 | S-Sale | 2.22 | 2026-01-16 |
| Anderson Kenneth Carl | director | 2026-01-02 | A-Award | 1.93 | 2026-01-05 |
| GROGAN DONNA ROY | director | 2026-01-02 | A-Award | 1.93 | 2026-01-05 |
| Mahaney Paige | officer: Chief Scientific Officer | 2025-10-28 | M-Exempt | 0 | 2025-10-30 |
| Mahaney Paige | officer: Chief Scientific Officer | 2025-10-28 | F-InKind | 2.58 | 2025-10-30 |
| Anderson Kenneth Carl | director | 2025-10-01 | A-Award | 2.15 | 2025-10-03 |
| GROGAN DONNA ROY | director | 2025-10-01 | A-Award | 2.15 | 2025-10-03 |
| Adams Kendra | officer: Chief Financial Officer | 2025-09-18 | M-Exempt | 0 | 2025-09-19 |
| Adams Kendra | officer: Chief Financial Officer | 2025-09-18 | F-InKind | 3.32 | 2025-09-19 |
| REYNO LEONARD | officer: Chief Medical Officer | 2025-07-10 | M-Exempt | 0 | 2025-07-15 |
| REYNO LEONARD | officer: Chief Medical Officer | 2025-07-10 | F-InKind | 1.99 | 2025-07-14 |
| Anderson Kenneth Carl | director | 2025-07-01 | A-Award | 1.51 | 2025-07-02 |
| GROGAN DONNA ROY | director | 2025-07-01 | A-Award | 1.51 | 2025-07-02 |
| Koppikar Utpal | director | 2025-06-18 | A-Award | 1.44 | 2025-06-20 |
| Hughes Owen | director | 2025-06-18 | A-Award | 1.44 | 2025-06-20 |
| Fawell Stephen | director | 2025-06-18 | A-Award | 1.44 | 2025-06-20 |
| Anderson Kenneth Carl | director | 2025-06-18 | A-Award | 1.44 | 2025-06-20 |
| Bessen Laura | director | 2025-06-18 | A-Award | 1.44 | 2025-06-20 |
| GROGAN DONNA ROY | director | 2025-06-18 | A-Award | 1.44 | 2025-06-20 |
| Cooper Ronald Harold Wilfred | director | 2025-06-18 | A-Award | 1.44 | 2025-06-20 |
| Hoerter Steven L. | director | 2025-06-18 | A-Award | 1.44 | 2025-06-20 |
| GROGAN DONNA ROY | director | 2025-04-01 | A-Award | 1.435 | 2025-04-03 |
| Anderson Kenneth Carl | director | 2025-04-01 | A-Award | 1.435 | 2025-04-03 |
| Hirsch Andrew | director, officer: President & CEO | 2025-02-14 | A-Award | 0 | 2025-02-18 |
| Hirsch Andrew | director, officer: President & CEO | 2025-02-14 | F-InKind | 3.18 | 2025-02-18 |
| Hirsch Andrew | director, officer: President & CEO | 2025-02-15 | F-InKind | 3.18 | 2025-02-18 |
| Hirsch Andrew | director, officer: President & CEO | 2025-02-14 | A-Award | 3.18 | 2025-02-18 |
| Siegel Jolie | officer: Chief Legal Officer | 2025-02-14 | A-Award | 0 | 2025-02-18 |
| Siegel Jolie | officer: Chief Legal Officer | 2025-02-14 | F-InKind | 3.18 | 2025-02-18 |
| Siegel Jolie | officer: Chief Legal Officer | 2025-02-14 | A-Award | 3.18 | 2025-02-18 |
| Siegel Jolie | officer: Chief Legal Officer | 2025-02-13 | F-InKind | 3.2 | 2025-02-18 |
| Boyle Scott N | officer: Chief Business Officer | 2025-02-14 | A-Award | 0 | 2025-02-18 |
| Boyle Scott N | officer: Chief Business Officer | 2025-02-14 | S-Sale | 3.15 | 2025-02-18 |
| Boyle Scott N | officer: Chief Business Officer | 2025-02-14 | F-InKind | 3.18 | 2025-02-18 |
| Boyle Scott N | officer: Chief Business Officer | 2025-02-18 | S-Sale | 3.15 | 2025-02-18 |
| Boyle Scott N | officer: Chief Business Officer | 2025-02-14 | A-Award | 3.18 | 2025-02-18 |
| Boyle Scott N | officer: Chief Business Officer | 2025-02-13 | F-InKind | 3.2 | 2025-02-18 |
| Mossler Mark | officer: Chief Accounting Officer | 2025-02-14 | F-InKind | 3.18 | 2025-02-18 |
| Schick Kelly | officer: Chief People Officer | 2025-02-14 | A-Award | 0 | 2025-02-18 |
| Schick Kelly | officer: Chief People Officer | 2025-02-14 | F-InKind | 3.18 | 2025-02-18 |
| Schick Kelly | officer: Chief People Officer | 2025-02-14 | A-Award | 3.18 | 2025-02-18 |
| Schick Kelly | officer: Chief People Officer | 2025-02-13 | F-InKind | 3.2 | 2025-02-18 |
| Adams Kendra | officer: Chief Financial Officer | 2025-02-14 | A-Award | 0 | 2025-02-18 |
| Adams Kendra | officer: Chief Financial Officer | 2025-02-14 | F-InKind | 3.18 | 2025-02-18 |
| Adams Kendra | officer: Chief Financial Officer | 2025-02-14 | A-Award | 3.18 | 2025-02-18 |
| Adams Kendra | officer: Chief Financial Officer | 2025-02-13 | F-InKind | 3.2 | 2025-02-18 |
| Mahaney Paige | officer: Chief Scientific Officer | 2025-02-14 | A-Award | 0 | 2025-02-18 |
| Mahaney Paige | officer: Chief Scientific Officer | 2025-02-14 | A-Award | 3.18 | 2025-02-18 |
| REYNO LEONARD | officer: Chief Medical Officer | 2025-02-14 | A-Award | 0 | 2025-02-18 |
| REYNO LEONARD | officer: Chief Medical Officer | 2025-02-14 | F-InKind | 3.18 | 2025-02-18 |
| REYNO LEONARD | officer: Chief Medical Officer | 2025-02-14 | A-Award | 3.18 | 2025-02-18 |
| GROGAN DONNA ROY | director | 2025-01-02 | A-Award | 3.66 | 2025-01-03 |
| Anderson Kenneth Carl | director | 2025-01-02 | A-Award | 3.66 | 2025-01-03 |
| Hoerter Steven L. | director | 2024-11-19 | A-Award | 4.15 | 2024-11-21 |
| Hoerter Steven L. | director: | 2024-11-19 | 0 | 2024-11-21 |